Butterfly Medical
Over the last 20 years, Mr. Hovard has held multiple leadership roles at subsidiaries of Coloplast, a publicly-traded global medical device company. Most recently, he served as the President of Interventional Urology from 2011 to 2019. At Interventional Urology, Mr. Hovard operated in a CEO capacity leading approximately 900 employees across corporate development with complete oversight of R&D, operations/manufacturing, marketing, sales, human resources, finance and legal.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Butterfly Medical
Butterfly Medical has developed a fast, non-invasive alternative treatment to first-line benign prostate hyperplasia medication & surgery.